EXOME

all the information, none of the junk | biotech • healthcare • life sciences

BSX Pays $22M in DOJ Settlement

Boston Scientific (NYSE:BSX) said yesterday that it has agreed to pay $22 million in a settlement related to a U.S. Department of Justice investigation of surveys conducted by the Natick, MA-based medical device firm’s subsidiary, Guidant. The company admitted no wrongdoing in the settlement. Reuters reported that the DOJ was investigating Guidant for paying doctors between $1,000 and $1,500 to use the firm’s heart implants and to increase sales of the products.